Free Trial
NASDAQ:AMED

Amedisys Q4 2023 Earnings Report

Amedisys logo
$96.14 +0.18 (+0.19%)
Closing price 07/3/2025 01:10 PM Eastern
Extended Trading
$96.14 0.00 (0.00%)
As of 07/3/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amedisys EPS Results

Actual EPS
$0.94
Consensus EPS
$1.04
Beat/Miss
Missed by -$0.10
One Year Ago EPS
$1.16

Amedisys Revenue Results

Actual Revenue
$570.79 million
Expected Revenue
$566.85 million
Beat/Miss
Beat by +$3.94 million
YoY Revenue Growth
+1.60%

Amedisys Announcement Details

Quarter
Q4 2023
Time
Q4 2023 Earnings Release
Conference Call Date
Wednesday, February 21, 2024
Conference Call Time
4:00PM ET

Upcoming Earnings

Amedisys' Q2 2025 earnings is scheduled for Wednesday, July 23, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Amedisys Earnings Headlines

Analyzing Amedisys (AMED) and Its Peers
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Amedisys (AMED) & The Competition Critical Survey
See More Amedisys Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Amedisys? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amedisys and other key companies, straight to your email.

About Amedisys

Amedisys (NASDAQ:AMED) is a leading provider of home health, hospice and personal care services in the United States. The company offers a range of clinical and supportive care solutions designed to help patients recover in the comfort of their homes or receive compassionate end-of-life support. Its service lines include skilled nursing, physical and occupational therapy, speech therapy, social work and hospice care, as well as home-based palliative care and telehealth monitoring. Amedisys emphasizes personalized care plans and multidisciplinary care teams to address both the clinical and emotional needs of patients and their families.

Founded in 1982 and headquartered in Baton Rouge, Louisiana, Amedisys has grown through a combination of organic expansion and targeted acquisitions. The company operates more than 400 care centers across over 30 states, serving urban, suburban and rural communities. Amedisys continually invests in clinical technology, electronic medical records and remote monitoring tools to enhance care coordination, improve patient outcomes and streamline communication among clinicians, patients and caregivers.

Throughout its history, Amedisys has focused on quality measures and regulatory compliance, earning accreditation and high marks from industry organizations. The company’s home health segment delivers post-acute care for patients with acute or chronic conditions, while its hospice segment provides emotional, spiritual and physical support for individuals facing terminal illness. Amedisys’s personal care services assist patients with activities of daily living, medication reminders and companionship, helping seniors and individuals with disabilities maintain independence.

Under the leadership of President and Chief Executive Officer Steve Stacy, Amedisys continues to pursue a strategy centered on patient-first care, strategic partnerships and community outreach. The executive team includes seasoned professionals in clinical operations, finance and quality assurance who guide initiatives in workforce development, regulatory affairs and innovation. By combining local presence with national scale, Amedisys aims to deliver cost-effective, high-quality care and meet evolving demand for home-based health services.

View Amedisys Profile

More Earnings Resources from MarketBeat